Quantitation of allograft fibrosis and chronic allograft nephropathy
- 1 November 1999
- journal article
- review article
- Published by Wiley in Pediatric Transplantation
- Vol. 3 (4) , 257-270
- https://doi.org/10.1034/j.1399-3046.1999.00044.x
Abstract
Despite improvements in the prevention and treatment of acute renal allograft rejection, the long‐term survival of renal transplants has not increased. Immunologic and non‐immunologic factors contribute to the gradual deterioration of graft function and to the histologic lesion characterized by vascular and interstitial fibrosis (‘chronic rejection’). Quantitation of this process has been attempted using various invasive and non‐invasive methods. These methods, performed at different times post‐transplant, are reviewed in this article. In particular, pathology scoring systems and the potential of using computerized image analysis of biopsy material are discussed.Keywords
This publication has 72 references indexed in Scilit:
- Transforming growth factor-β1 and lung allograft fibrosis1European Journal of Cardio-Thoracic Surgery, 1998
- Compliance with cyclosporine in adolescent renal transplant recipients.Pediatric Nephrology, 1997
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Chronic renal transplant lossKidney International, 1995
- BOTH ALLOANTIGEN-DEPENDENT AND -INDEPENDENT FACTORS INFLUENCE CHRONIC ALLOGRAFT REJECTIONTransplantation, 1995
- Chronic transplant rejectionKidney International, 1994
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Histopathological findings in well-functioning, long-term renal allograftsKidney International, 1992
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983